Zhang Z - Search Results

1

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.

Wang J, Luo F, Feng Z, Li L, Bai Y, Ai X, Ma J, Zhang Z, Shi N. Wang J, et al. Among authors: zhang z. Hum Vaccin Immunother. 2017 Jan 2;13(1):144-150. doi: 10.1080/21645515.2016.1230260. Hum Vaccin Immunother. 2017. PMID: 28045585 Free PMC article. Clinical Trial.

2

HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naïve MSM from 2011 to 2013 in Beijing, China.

Jiao Y, Li S, Li Z, Zhang Z, Zhao J, Li L, Wang L, Yin Q, Wang Y, Zeng Z, Shao Y, Ma L. Jiao Y, et al. Among authors: zhang z. BMC Infect Dis. 2014 Dec 16;14:689. doi: 10.1186/s12879-014-0689-7. BMC Infect Dis. 2014. PMID: 25510523 Free PMC article.

3

Immunological persistence of a seasonal influenza vaccine in people more than 3 years old.

Bai Y, Shi N, Lu Q, Yang L, Wang Z, Li L, Han H, Zheng D, Luo F, Zhang Z, Ai X. Bai Y, et al. Among authors: zhang z. Hum Vaccin Immunother. 2015;11(7):1648-53. doi: 10.1080/21645515.2015.1037998. Hum Vaccin Immunother. 2015. PMID: 26083828 Free PMC article. Clinical Trial.

4

Incidence of Co-Infections of HIV, Herpes Simplex Virus Type 2 and Syphilis in a Large Cohort of Men Who Have Sex with Men in Beijing, China.

Li D, Yang X, Zhang Z, Wang Z, Qi X, Ruan Y, Zhou Y, Li C, Luo F, Lau JT. Li D, et al. Among authors: zhang z. PLoS One. 2016 Jan 28;11(1):e0147422. doi: 10.1371/journal.pone.0147422. eCollection 2016. PLoS One. 2016. PMID: 26820145 Free PMC article.

5

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.

Shi N, Zhang Y, Zheng H, Zhu Z, Wang D, Li S, Li Y, Yang L, Zhang J, Bai Y, Lu Q, Zhang Z, Luo F, Yu C, Li L. Shi N, et al. Among authors: zhang j, zhang z, zhang y. Hum Vaccin Immunother. 2017 Jun 3;13(6):1-8. doi: 10.1080/21645515.2017.1279770. Epub 2017 Jan 25. Hum Vaccin Immunother. 2017. PMID: 28121231 Free PMC article.

6

Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus.

Shi N, Lu Q, Zhang J, Li L, Zhang J, Zhang F, Dong Y, Zhang X, Zhang Z, Gao W. Shi N, et al. Among authors: zhang f, zhang j, zhang z, zhang x. Hum Vaccin Immunother. 2017 Jun 3;13(6):1-7. doi: 10.1080/21645515.2016.1239669. Epub 2017 Apr 14. Hum Vaccin Immunother. 2017. PMID: 28409676 Free PMC article.

7

Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour.

Ma J, Qi X, Chen H, Li X, Zhang Z, Wang H, Sun L, Zhang L, Guo J, Morawska L, Grinshpun SA, Biswas P, Flagan RC, Yao M. Ma J, et al. Among authors: zhang l, zhang z. Clin Infect Dis. 2021 May 18;72(10):e652-e654. doi: 10.1093/cid/ciaa1283. Clin Infect Dis. 2021. PMID: 32857833 Free PMC article.

8

Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.

Zhang J, Hu Z, He J, Liao Y, Li Y, Pei R, Fang X, Zeng P, Fan R, Ou Z, Deng J, Zhou J, Guan W, Min Y, Deng F, Peng H, Zhang Z, Feng C, Xin B. Zhang J, et al. Among authors: zhang z. Emerg Microbes Infect. 2021 Dec;10(1):1589-1597. doi: 10.1080/22221751.2021.1951126. Emerg Microbes Infect. 2021. PMID: 34197281 Free PMC article. Clinical Trial.

9

Immunogenicity and safety of a recombinant fusion protein vaccine (V-01) against coronavirus disease 2019 in healthy adults: a randomized, double-blind, placebo-controlled, phase II trial.

Shu YJ, He JF, Pei RJ, He P, Huang ZH, Chen SM, Ou ZQ, Deng JL, Zeng PY, Zhou J, Min YQ, Deng F, Peng H, Zhang Z, Wang B, Xu ZH, Guan WX, Hu ZY, Zhang JK. Shu YJ, et al. Among authors: zhang z, zhang jk. Chin Med J (Engl). 2021 Jul 22;134(16):1967-1976. doi: 10.1097/CM9.0000000000001702. Chin Med J (Engl). 2021. PMID: 34310400 Free PMC article. Clinical Trial.

10

Persistence of Immunity in Adults after 1, 5 and 10 Years with Recombinant Hepatitis B Vaccine in Beijing in 2010-2020.

Shen S, Ge S, Zhang Z, Ma J, Jiao Y, Li Q, Liang Y, Li S. Shen S, et al. Among authors: zhang z. Vaccines (Basel). 2022 Jan 25;10(2):181. doi: 10.3390/vaccines10020181. Vaccines (Basel). 2022. PMID: 35214640 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102,508 results

Search Page